SPY304.41+0.09 0.03%
DIA253.85-0.44 -0.17%
IXIC9,509.07+19.20 0.20%

Blueprint Medicines Reports Receives Complete Response Letter From FDA For Avapritinib New Drug Application For Treatment Of Fourth-Line Gastrointestinal Stromal Tumor

Benzinga · 05/15/2020 12:06